Table 1 Patient characteristics.
| Variable | |
|---|---|
| Number of patients | 98 |
| Age, years | 73±7.3 |
| Male sex | 79 (81%) |
| Infrainguinal lesion | 72 (73.5%) |
| CLI | 26 (26.5%) |
| ABI | 0.56±0.21 |
| BMI, kg/m2 | 22.4±3.3 |
| Smoking | 72 (73.5%) |
| Comorbidities | |
| Hypertension | 72 (73.5%) |
| DM | 43 (43.9%) |
| CVD | 31 (31.6%) |
| IHD | 36 (36.7%) |
| HD | 13 (13.3%) |
| ω-3 fatty acids | |
| EPA, µg/mL | 70.5±41.4 |
| DHA, µg/mL | 139.2±53.3 |
| AA, µg/mL | 174.2±44.8 |
| DHLA, µg/mL | 36.0±13.8 |
| Serum lipids | |
| TC, mg/dL | 176.4±36.2 |
| TG, mg/dL | 151.7±85.9 |
| HDL, mg/dL | 46.36±13.9 |
| LDL, mg/dL | 99.81±33.5 |
The values are presented as n (%) or mean±standard deviation, as appropriate. CLI: critical limb ischemia; ABI: ankle–brachial pressure index; BMI: body mass index; DM: diabetes mellitus; CVD: cerebrovascular disease; IHD: ischemic heart disease; HD: hemodialysis; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; AA: arachidonic acid; DHLA: dihomo-γ-linolenic acid; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein